Phase
Condition
Pain (Pediatric)
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
≥ 18 years of age
Newly diagnosed with a primary tumor of one of the following malignant neoplasms:colon (C18), rectum (C19-20), liver (C22), pancreas (C25), lung (C33-34), malignantmelanoma (C43), breast (C50, only female), cervix (C53), endometrium (C54.1),ovaries (C56), prostate (C61), kidney (C64), bladder (C67), thyroid gland (C73),non-Hodgkin lymphoma (C82-88), leukemia (C91-C95)
Having received or receiving at enrolment at least one of the following treatments:chemotherapy, radiotherapy, hormone therapy, targeted or immune therapy
Able to understand and follow the study protocol
Exclusion
Exclusion Criteria:
Carcinoma in situ
Any additional malignant or unclear neoplasm before or since time of diagnosis ofthe considered primary tumor, except unspecified neoplasm of skin (C44)
Study Design
Study Description
Connect with a study center
German Cancer Research Center
Heidelberg,
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.